TIL |
Instil Bio, Inc. |
113.29M |
3.59% |
|
|
|
|
|
17.36 |
-3.98% |
576.12% |
75.97% |
---|
REPL |
Replimune Group, Inc. |
750.89M |
3.54% |
|
|
|
|
|
9.75 |
-6.16% |
122.01% |
15.94% |
---|
IOVA |
Iovance Biotherapeutics, Inc. |
1.09B |
3.47% |
|
|
|
|
|
3.33 |
-6.46% |
70.61% |
30.68% |
---|
ZYME |
Zymeworks Inc. |
828.66M |
3.45% |
|
|
|
|
|
11.91 |
-3.72% |
291.26% |
53.33% |
---|
ARGX |
argenx SE |
35.96B |
3.42% |
|
|
|
|
|
591.87 |
0.46% |
31.77% |
34.01% |
---|
GMAB |
Genmab A/S |
12.46B |
3.42% |
|
|
|
|
|
19.58 |
-1.61% |
74.56% |
33.21% |
---|
AZN |
AstraZeneca PLC |
227.94B |
3.39% |
|
|
|
|
|
73.50 |
-0.39% |
30.00% |
74.03% |
---|
BMY |
Bristol-Myers Squibb Company |
124.10B |
3.39% |
|
|
|
|
|
60.99 |
1.62% |
39.10% |
100.05% |
---|
CRSP |
CRISPR Therapeutics AG |
2.92B |
3.39% |
|
|
|
|
|
34.03 |
-8.00% |
65.44% |
77.15% |
---|
MRK |
Merck & Co., Inc. |
226.74B |
3.37% |
|
|
|
|
|
89.76 |
0.59% |
38.46% |
98.43% |
---|
NKTR |
Nektar Therapeutics |
126.55M |
3.37% |
|
|
|
|
|
0.6800 |
-7.90% |
288.36% |
59.96% |
---|
XNCR |
Xencor, Inc. |
749.71M |
3.37% |
|
|
|
|
|
10.64 |
-5.25% |
81.40% |
81.36% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
68.18B |
3.36% |
|
|
|
|
|
634.23 |
-0.49% |
44.03% |
94.27% |
---|
FATE |
Fate Therapeutics, Inc. |
90.54M |
3.33% |
|
|
|
|
|
0.7901 |
-6.97% |
236.51% |
64.93% |
---|
GILD |
Gilead Sciences, Inc. |
139.54B |
3.33% |
|
|
|
|
|
112.05 |
0.23% |
32.76% |
76.20% |
---|
RCUS |
Arcus Biosciences, Inc. |
830.85M |
3.32% |
|
|
|
|
|
7.85 |
-3.92% |
286.49% |
39.02% |
---|
ATRA |
Atara Biotherapeutics, Inc. |
34.80M |
3.30% |
|
|
|
|
|
5.94 |
-9.04% |
769.79% |
94.72% |
---|
ALLO |
Allogene Therapeutics, Inc. |
317.21M |
3.29% |
|
|
|
|
|
1.4600 |
-5.81% |
677.77% |
57.74% |
---|
RUBY |
Rubius Therapeutics, Inc. |
|
3.29% |
|
|
|
|
|
|
|
|
|
---|
TRIL |
Trillium Therapeutics Inc. |
|
3.29% |
|
|
|
|
|
|
|
|
|
---|
BLUE |
bluebird bio, Inc. |
47.54M |
3.28% |
|
|
|
|
|
4.88 |
19.61% |
122.15% |
7.08% |
---|
IBRX |
ImmunityBio, Inc. |
2.57B |
3.28% |
|
|
|
|
|
3.01 |
-4.14% |
162.94% |
34.84% |
---|
IMAB |
I-Mab |
29.20M |
3.25% |
|
|
|
|
|
0.8239 |
-2.07% |
546.25% |
N/A |
---|
IGMS |
IGM Biosciences, Inc. |
68.38M |
3.23% |
|
|
|
|
|
1.1500 |
-7.26% |
187.84% |
100.00% |
---|
STTK |
Shattuck Labs, Inc. |
45.36M |
3.23% |
|
|
|
|
|
0.9501 |
-9.94% |
586.39% |
69.64% |
---|
ALXO |
ALX Oncology Holdings Inc. |
33.26M |
3.21% |
|
|
|
|
|
0.6230 |
-4.90% |
270.19% |
38.96% |
---|
LEGN |
Legend Biotech Corporation |
3.12B |
3.20% |
|
|
|
|
|
33.93 |
-3.22% |
65.05% |
26.80% |
---|
BGNE |
BeiGene, Ltd. |
|
3.19% |
|
|
|
|
|
|
|
|
|
---|
MGNX |
MacroGenics, Inc. |
80.12M |
3.17% |
|
|
|
|
|
1.2700 |
0.79% |
120.94% |
33.32% |
---|
YMAB |
Y-mAbs Therapeutics, Inc. |
200.32M |
3.12% |
|
|
|
|
|
4.43 |
-7.90% |
299.13% |
43.09% |
---|
Cash&Other |
|
|
0.13% |
|
|
|
|
|
|
|
|
|
---|